Medicine

Creating a low-cost ventilator for all

ETH Professor Kristina Shea and her team are busy developing a new ventilator. Their aim is to make it as inexpensive, modular and easy to use as possible – the ideal combination for any country that needs this medical device.

Peptides that can be taken as a pill

Peptides represent a billion-dollar market in the pharmaceutical industry, but they can generally only be taken as injections to avoid degradation by stomach enzymes. Scientists at EPFL have now developed a method to generate peptides that resist enzymatic degradation and can be taken orally.

Flowbone can help prevent bone fractures caused by osteoporosis

EPFL scientists have developed a gel that can locally reinforce bones weakened by osteoporosis. The startup they created, called Flowbone, has just made it through the second round of the Venture Kick competition.

Why does COVID-19 affect old people more than young people?

As we age, our lung tissue becomes stiffer – and this is a phenomenon that SARS-CoV-2 may be exploiting. Caroline Uhler and G. V. Shivashankar outline their hypothesis.

WIITE, the exoskeleton for backcountry skiing

While backcountry ski racers are disappointed that they won’t be starting the Patrouille des Glaciers, one disabled skier is happily strapping on the climbing skins once again. The designers of TWIICE adapted their exoskeleton so that it can be used to skin up mountains.

Research into drugs and vaccines to combat Covid-19

As the world anxiously awaits a remedy for the novel coronavirus, ETH Zurich is also involved in the search for active substances and vaccines. This overview sets out the therapeutic approaches pursued by ETH researchers.

3 4 5

6

7 8 9 10...

Page 6 of 11